Supply of Medicine and Medical / Surgical equipments : Anti C Sera 5ml/vial\n1. The method of manufacture should result\nin a product within an immediate container\nthat is homogeneous and free of properties\nwhich adversely affect its intended use\nthroughout its recommended shelf life. The\nreagent should have no precipitate, particles\nor fibrin gel.\n2. Each batch or sub-batch should be\nspecifically identified by a distinctive\ncombination of numbers and/or letters (batch\nreference) which permits its history to be\ntraced.\n3. Reagents should be produced by a\nvalidated process that is shown to be suitable\nfor the intended purpose.\n4. Volume should be mentioned in milliliters\n(ml) on immediate container\n5. Absence of rouleaux formation, prozone\nand haemolysis.\n6. Labelling requirements; A. Should have a\nlabel on the immediate container B. Printing\non all final container labels shall be in solid\nblack. C. The label fixed to the immediate\ncontainer of a reagent should lea

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Anti C Sera 5ml/vial\n1. The method of manufacture should result\nin a product within an immediate container\nthat is homogeneous and free of properties\nwhich adversely affect its intended use\nthroughout its recommended shelf life. The\nreagent should have no precipitate, particles\nor fibrin gel.\n2. Each batch or sub-batch should be\nspecifically identified by a distinctive\ncombination of numbers and/or letters (batch\nreference) which permits its history to be\ntraced.\n3. Reagents should be produced by a\nvalidated process that is shown to be suitable\nfor the intended purpose.\n4. Volume should be mentioned in milliliters\n(ml) on immediate container\n5. Absence of rouleaux formation, prozone\nand haemolysis.\n6. Labelling requirements; A. Should have a\nlabel on the immediate container B. Printing\non all final container labels shall be in solid\nblack. C. The label fixed to the immediate\ncontainer of a reagent should lea in Pharmaceuticals. The tender was released on Feb 14, 2025.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Anti C Sera 5ml/vial\n1. The method of manufacture should result\nin a product within an immediate container\nthat is homogeneous and free of properties\nwhich adversely affect its intended use\nthroughout its recommended shelf life. The\nreagent should have no precipitate, particles\nor fibrin gel.\n2. Each batch or sub-batch should be\nspecifically identified by a distinctive\ncombination of numbers and/or letters (batch\nreference) which permits its history to be\ntraced.\n3. Reagents should be produced by a\nvalidated process that is shown to be suitable\nfor the intended purpose.\n4. Volume should be mentioned in milliliters\n(ml) on immediate container\n5. Absence of rouleaux formation, prozone\nand haemolysis.\n6. Labelling requirements; A. Should have a\nlabel on the immediate container B. Printing\non all final container labels shall be in solid\nblack. C. The label fixed to the immediate\ncontainer of a reagent should lea

Deadline - login to view

GT reference number - 103330964

Product classification - Pharmaceutical products